News

Second patient death reported with gene therapy for muscular dystrophy
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in ...
Capricor Therapeutics Announces Orphan Drug Designation for Becker Muscular Dystrophy and Regulatory Progress for Duchenne Muscular Dystrophy Program
U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s ...
Big Rapids Pioneer4h
Reed City brothers with muscular dystrophy receive new van
The boys live in Reed City with their mother Tabatha; father Michael, who is the Osceola County Road Commission manager and ...
Capricor Therapeutics' Becker Muscular Dystrophy Drug Gets Orphan Drug Designation in U.S.
Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...
'My son, 12, can't have FREE life-changing drug because of where we live - it’s a race against time’
No mother should have to watch their child suffer, but one woman shares what it's like witnessing her 12-year-old boy slowly ...
BIO chair: U.S. has a ‘crisis’ on drug costs
The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.
Explore more
STAT9h
Lilly adds highest Zepbound doses to DTC offering
Eli Lilly is buying Verve Therapeutics, developer of gene-editing treatments for cardiovascular disease, for $1 billion plus ...
1 Oversold Stock Primed to Rebound and 2 to Steer Clear Of
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, ...
Teen Missed His High School Graduation While Waiting for Heart Transplant, so His Hospital Threw Him a Ceremony Instead
"There were tears everywhere," Hana Herrick, school services coordinator at Lurie Children’s Hospital, tells PEOPLE ...
Capricor gets FDA's Orphan Drug status for muscle disorder therapy
Capricor Therapeutics (NASDAQ:CAPR) received the Orphan Drug designation from the U.S. FDA for its lead cell therapy candidate, Deramiocel, to treat becker muscular dystrophy. With its orphan drug ...